0001104659-21-110596.txt : 20210827 0001104659-21-110596.hdr.sgml : 20210827 20210827170125 ACCESSION NUMBER: 0001104659-21-110596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210825 FILED AS OF DATE: 20210827 DATE AS OF CHANGE: 20210827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coiante Scott M CENTRAL INDEX KEY: 0001608536 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 211219927 MAIL ADDRESS: STREET 1: 101 POOR FARM ROAD 3RD FLOOR CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 tm2126037-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-08-25 0 0001781983 Aprea Therapeutics, Inc. APRE 0001608536 Coiante Scott M 535 BOYLSTON STREET BOSTON MA 02116 0 1 0 0 SVP, Chief Financial Officer Common Stock 2021-08-25 4 F 0 7534 3.98 D 91466 D Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 21,166 restricted stock units. /s/ Scott M. Coiante 2021-08-27